Effect of Lactulose and Fiber-rich Diets on Bile in Relation to Gallstone Disease: an Update

REFERENCES

• Portincasa P, Stolk MFJ, Van Erpecum KJ, Palasciano G, VanBerge-Henegouwen GP. Cholesterol gallstone formation in man and potential treatments of the gallbladder motility defect. Scand J Gastroenterol 1995;30 Suppl 212: 63–78.
   Google Scholar
• Van Erpecum KJ, VanBerge-Henegouwen GP, Stoelwinder B, Schmidt YMG, Willekens FLH. Bile concentration is a key factor for nucleation of cholesterol crystals and cholesterol saturation index in gallbladder bile of gallstone patients. Hepatology 1990;11: 1–6.
   PubMed Web of Science ®Google Scholar
• Villanova N, Bazzoli F, Taroni F, Frabboni R, Mazzella G, Festi D, et al. Gallstone recurrence after successful oral bile acid treatment: a 12 year follow-up study and evaluation of long-term post-dissolution treatment. Gastroenterology 1989;97: 726–31.
   PubMed Web of Science ®Google Scholar
• Groen AK, Noordam C, Drapers JAG, Egbers P, Jansen PLM, Tytgat GNJ. Isolation of a potent cholesterol nucleation- promoting activity from human gallbladder bile of patients with solitary or multiple cholesterol gallstones. Hepatology 1990;11: 525–33.
   PubMed Web of Science ®Google Scholar
• Portincasa P, Van Erpecum KJ, Van de Meeberg P, Dullinga-Thie GM, De Bruin TWA, VanBerge-Henegouwen GP. Apolipoprotein E genotype and gallbladder motility influence speed of gallstone clearance and risk of recurrence after extracorporeal shock-wave lithotripsy. Hepatology 1996;24: 580–7.
   PubMed Web of Science ®Google Scholar
• Marcus SN, Heaton KW. Deoxycholic acid and the pathogenesis of gallstones. Gut 1988;29: 522–33.
   PubMed Web of Science ®Google Scholar
• Marcus SN, Heaton KW. Intestinal transit, deoxycholic acid and the cholesterol saturation of bile—three interrelated factors. Gut 1986;27: 550–8.
   PubMed Web of Science ®Google Scholar
• Heaton KW, Emmett PM, Symes CL, Braddon FEM. An explanation for gallstones in normal-weight women: slow intestinal transit. Lancet 1993;341: 8–10.
   PubMed Web of Science ®Google Scholar
• Shoda J, He B-F, Tanaka N, Matsuzaki Osuga T, Yamamori S, Miyazaki H, Sjovall J. Increase of deoxycholate in supersaturated bile of patients with cholesterol gallstone disease and its correlation with de novo syntheses of cholesterol and bile acids in liver, gallbladder emptying, and small intestinal transit. Hepatology 1995;21: 1291–302.
   PubMed Web of Science ®Google Scholar
• Hussani SH, Murphy GM, Kennedy C, Besser GM, Wass JAH, Dowling RH. The role of bile composition and physical chemistry in the pathogenesis of octreotide-associated gallbladder stones. Gastroenterology 1994;107: 1503–13.
   PubMed Web of Science ®Google Scholar
• Berr F, Pratschke E, Fischer S, Paumgartner G. Disorders of bile acid metabolism in cholesterol gallstone disease. J Clin Invest 1992;90: 859–68.
   PubMed Web of Science ®Google Scholar
• Vlahcevic ZR, Bell Jr CC, Buhac I, Farrar JT, Swell L. Diminished bile acid pool size in patients with gallstones. Gastroenterology 1970;59: 165–73.
   PubMed Web of Science ®Google Scholar
• Shaffer EA, Small DM. Biliary lipid secretion in cholesterol gallstone disease. The effect of cholecystectomy and obesity. J Clin Invest 1977;59: 828–40.
   PubMed Web of Science ®Google Scholar
• Nilsell KB, Angelin B, Leijd B, Einarsson K. Biliary lipid output and bile acid kinetics in cholesterol gallstone disease. Gastroenterology 1985;89: 287–93.
   PubMed Web of Science ®Google Scholar
• Carulli N, Loria P, Bertolotti C, Ponz de Leon M, Menozzi D, Medici G, Piccagli I. Effects of acute changes in bile acid pool composition on biliary lipid secretion. J Clin Invest 1985;74: 616–24.
   Google Scholar
• Xu Q-W, Shaffer EA. Octreotide inhibits biliary lipid secretion and GB motility: relation to cholesterol gallstone formation. Gastroenterology 1995;108: A442.
   Google Scholar
• Xu Q-W, Scott RB, Tan DTM, Shaffer EA. Slow intestinal transit: an added motility disorder in cholesterol gallstone formation. Gastroenterology 1995;108: A442.
   Google Scholar
• Xu Q-W, Scott RB, Tan DTM, Shaffer EA. Erythromycin as a prokinetic agent in an animal model of cholesterol gallstone disease. Gastroenterology 1995;108: A441.
   PubMed Web of Science ®Google Scholar
• Attili AF, Carulli M, Roda E, Barbara L, Capocaccia L, Menotti A, the M.I.C.O.L. group. Epidemiology of gallstone disease in Italy: prevalence data of the multicenter Italian Study on cholelithiasis (M.I.C.O.L.). Am J Epidemiol 1995;141: 158–65.
   PubMed Web of Science ®Google Scholar
• Van der Werf SDJ, Huybregts AWM, Lamers HLM, VanBerge- Henegouwen GP. Age-dependent differences in human bile acid metabolism and 7α-dehydroxylation. Eur J Clin Invest 1981;11: 425–31.
   PubMed Web of Science ®Google Scholar
• Einarsson K, Milsell K, Björkhem I. Increased oxidoreduction of deoxycholic acid in cholecystectomised patients. Gut 1989;30: 1275–8.
   PubMed Web of Science ®Google Scholar
• Stellaard F, Paumgartner G, VanBerge-Henegouwen GP, Van der Werf SDJ. Determination of deoxycholic acid pool size and input rate using (24-13C) deoxycholic acid and serum sampling. J Lipid Res 1986;27: 1222–5.
   PubMed Web of Science ®Google Scholar
• Stolk MFJ, Van de Heijning BJM, Van Erpecum KJ, Van de Broek AMWC, Renooij W, VanBerge-Henegouwen GP. The effect of bile salt hydrophobicity on nucleation of several types of cholesterol crystals from model bile vesicles. J Hepatology 1994;20: 802–10.
   PubMed Web of Science ®Google Scholar
• Portincasa P, Van Erpecum KJ, Jansen A, Renooij W, Gadellaa M, VanBerge-Henegouwen GP. Nucleation behaviour of various cholesterol crystals in bile from gallstone patients. Hepatology 1996;23: 738–48.
   PubMedGoogle Scholar
• Van Erpecum KJ, Portincasa P, Gadellaa M, Van de Heijning BJM, Renooij W, VanBerge-Henegouwen GP. Effects of bile salt hydrophobicity on nucleation behaviour of cholesterol crystals in model bile. Eur J Clin Invest 1996 (In press).
   Google Scholar
• Van de Heijning BJM, Stolk MFJ, Van Erpecum KJ, Renooij W, Groen AK, VanBerge-Henegouwen GP. Bile salt induced cholesterol crystal formation from model bile vesicles: a time- course study. J Lipid Res 1994;35: 1002–11.
   PubMed Web of Science ®Google Scholar
• Konikoff FM, Chung DS, Donovan JM, Small DM, Carey MC. Filamentous, helical and tubular microstructures during cholesterol crystallization from bile. Evidence that biliary cholesterol does not nucleate classic monohydrate plates. J Clin Invest 1992;90: 1156–61.
   Google Scholar
• Juste C, Catala I, Henry R, Chabanet C, Gucugneau ABM, Beguel F, et al. Influence of bile salt molecular species on cholesterol crystallization from supersaturated model biles. Biochem Biophys Acta 1995;1254: 88–97.
   Google Scholar
• Thornton JR, Heaton KW. Do colonic bacteria contribute to cholesterol gallstone formation? Effects of lactulose on bile. Br Med J 1981;1: 1018–20.
   Google Scholar
• VanBerge-Henegouwen GP, Van der Werf SDJ, Ruben AT. Effect of lactulose on biliary lipid composition. J Hepatology 1986;3: 328–32.
   PubMed Web of Science ®Google Scholar
• VanBerge-Henegouwen GP, Van der Werf SDJ, Ruben AT. Effect of longterm lactulose ingestion on secondary bile salt metabolism in man: potential protective effect of lactulose in colonic carcinogenesis. Gut 1987;28: 675–80.
   PubMed Web of Science ®Google Scholar
• Huybregts AWM, VanBerge-Henegouwen GP, Hectors MPC, Van Schaik A, Van der Werf SDJ. Effects of a standardized wheat bran preparation on biliary lipid composition and bile acid metabolism in young healthy males. Eur J Clin Invest 1980; 10: 451–8.
   PubMed Web of Science ®Google Scholar
• McDougall RM, Yakymyshyn L, Walker K, Thurston OG. The effect of wheat bran on serum lipoproteins and biliary lipids. Can J Surg 1978;21: 433–5.
   PubMed Web of Science ®Google Scholar
• Wiseman LR, Faulds D. Cisapride. An updated review of its pharmacology and therapeutic efficacy as a prokinetic agent in gastro-intestinal motility disorders. Drugs 1994;47: 116–52.
   PubMed Web of Science ®Google Scholar
• Dowling RH, Gleeson DC, Hood KA, Ruppin DC, the British- Belgian Gallstone Study Group. Gallstone Recurrence and Postdissolution Management. In Paumgartner G, Stiehl A, Gerok W, editors. Bile acids and the liver. Lancaster, UK: Kluwer 1987: 355–67.
   Google Scholar